Identification and characterization of a peculiar vtx2-converting phage frequently present in verocytotoxin-producing Escherichia coli O157 isolated from human infections

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 3023-3032

  Tozzoli, Rosangela ^a   Grande, Laura ^a   Michelacci, Valeria ^a   Fioravanti, Rosa ^a,e   Gally, David ^b   Xu, Xuefang ^b,f   Ragione, Roberto La ^c,d   Anjum, Muna ^c   Wu, Guanghui ^c   Caprioli, Alfredo ^a   Morabito, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e ROMA TRE UNIVERSITY   (Italy)

^f CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; INTESTINE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY ISLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TYPE III SECRETION SYSTEM;

ANIMALS; CATTLE; CATTLE DISEASES; COLIPHAGES; DNA, VIRAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENOME, VIRAL; GENOTYPE; HUMANS; ITALY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SHIGA TOXIN 2;

EID: 84903218288     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01836-14     Document Type: Article

References (47)

1. Griffin PM, Tauxe RV. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98.
2. Armstrong GL, Hollingsworth J, Morris JG, Jr. 1996. Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev. 18:29-51. http://dx.doi.org/10.1093/oxfordjournals.epirev.a017914.
3. Chase-Topping ME, McKendrick IJ, Pearce MC, MacDonald P, Matthews L, Halliday J, Allison L, Fenlon D, Low JC, Gunn G, Woolhouse ME. 2007. Risk factors for the presence of high-level shedders of Escherichia coli O157 on Scottish farms. J. Clin. Microbiol. 45:1594-1603. http://dx.doi.org/10.1128/JCM.01690-06.
4. Chase-Topping M, Gally D, Low C, Matthews L, Woolhouse M. 2008. Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157. Nat. Rev. Microbiol. 6:904-912. http://dx.doi.org/10.1038/nrmicro2029.
5. Michel P, Wilson JB, Martin SW, Clarke RC, McEwen SA, Gyles CL. 1999. Temporal and geographical distributions of reported cases of Escherichia coli O157:H7 infection in Ontario. Epidemiol. Infect. 122:193-200. http://dx.doi.org/10.1017/S0950268899002083.
6. Low JC, McKendrick IJ, McKechnie C, Fenlon D, Naylor SW, Currie C, Smith DG, Allison L, Gally DL. 2005. Rectal carriage of enterohemorrhagic Escherichia coli O157 in slaughtered cattle. Appl. Environ. Microbiol. 71:93-97. http://dx.doi.org/10.1128/AEM.71.1.93-97.2005.
7. Hancock DD, Besser TE, Kinsel ML, Tarr PI, Rice DH, Paros MG. 1994. The prevalence of Escherichia coli O157.H7 in dairy and beef cattle in Washington State. Epidemiol. Infect. 113:199-207. http://dx.doi.org/10.1017/S0950268800051633.
8. O'Brien SJ, Adak GK, Gilham C. 2001. Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans. Emerg. Infect. Dis. 7:1049-1051. http://dx.doi.org/10.3201/eid0706.010626.
9. Strachan NJ, Dunn GM, Locking ME, Reid TM, Ogden ID. 2006. Escherichia coli O157: burger bug or environmental pathogen? Int. J. Food Microbiol. 112:129-137. http://dx.doi.org/10.1016/j.ijfoodmicro.2006.06.021.
10. Huang A, Friesen J, Brunton JL. 1987. Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli. J. Bacteriol. 169:4308-4312.
11. Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921. http://dx.doi.org/10.1046/j.1365-2958.1998.01144.x.
12. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 92:1664-1668. http://dx.doi.org/10.1073/pnas.92.5.1664.
13. Delahay RM, Frankel G, Knutton S. 2001. Intimate interactions of enteropathogenic Escherichia coli at the host cell surface. Curr. Opin. Infect. Dis. 14:559-565. http://dx.doi.org/10.1097/00001432-200110000-00009.
14. Khakhria R, Duck D, Lior H. 1990. Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol. Infect. 105:511-520. http://dx.doi.org/10.1017/S0950268800048135.
15. Mora A, Blanco M, Blanco JE, Alonso MP, Dhabi G, Thomson-Carter F, Usera MA, Bartolome R, Prats G, Blanco J. 2004. Phage types and genotypes of Shiga toxin-producing Escherichia coli O157:H7 isolates from humans and animals in Spain: identification and characterization of two predominating phage types (PT2 and PT8). J. Clin. Microbiol. 42: 4007-4015. http://dx.doi.org/10.1128/JCM.42.9.4007-4015.2004.
16. Kappeli U, Hachler H, Giezendanner N, Cheasty T, Stephan R. 2011. Shiga toxin-producing Escherichia coli O157 associated with human infections in Switzerland, 2000-2009. Epidemiol. Infect. 139:1097-1104. http://dx.doi.org/10.1017/S0950268810002190.
17. Stirling A, McCartney G, Ahmed S, Cowden J. 2007. An outbreak of Escherichia coli O157 phage type 2 infection in Paisley, Scotland. Euro Surveill. 12:E070823.1.
18. Hart J, Smith G. 2009. Verocytotoxin-producing Escherichia coli O157 outbreak in Wrexham, North Wales, July 2009. Euro Surveill. 14:19300.
19. Locking M, Allison L, Rae L, Pollock K, Hanson M. 2006. VTEC infections and livestock-related exposures in Scotland, 2004. Euro Surveill. 11:E060223.4.
20. Matthews L, Reeve R, Gally DL, Low JC, Woolhouse ME, McAteer SP, Locking ME, Chase-Topping ME, Haydon DT, Allison LJ, Hanson MF, Gunn GJ, Reid SW. 2013. Predicting the public health benefit of vaccinating cattle against Escherichia coli O157. Proc. Natl. Acad. Sci. U. S. A. 110:16265-16270. http://dx.doi.org/10.1073/pnas.1304978110.
21. Dowd SE, Ishizaki H. 2006. Microarray based comparison of two Escherichia coli O157:H7 lineages. BMC Microbiol. 6:30. http://dx.doi.org/10.1186/1471-2180-6-30.
22. Yang Z, Kovar J, Kim J, Nietfeldt J, Smith DR, Moxley RA, Olson ME, Fey PD, Benson AK. 2004. Identification of common subpopulations of non-sorbitol-fermenting, beta-glucuronidase-negative Escherichia coli O157:H7 from bovine production environments and human clinical samples. Appl. Environ. Microbiol. 70:6846-6854. http://dx.doi.org/10.1128/AEM.70.11.6846-6854.2004.
23. Kim J, Nietfeldt J, Benson AK. 1999. Octamer-based genome scanning distinguishes a unique subpopulation of Escherichia coli O157:H7 strains in cattle. Proc. Natl. Acad. Sci. U. S. A. 96:13288-13293. http://dx.doi.org/10.1073/pnas.96.23.13288.
24. Manning SD, Motiwala AS, Springman AC, Qi W, Lacher DW, Ouellette LM, Mladonicky JM, Somsel P, Rudrik JT, Dietrich SE, Zhang W, Swaminathan B, Alland D, Whittam TS. 2008. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. U. S. A. 105:4868-4873. http://dx.doi.org/10.1073/pnas.0710834105.
25. van Hoek AH, Aarts HJ, Bouw E, van Overbeek WM, Franz E. 2013. The role of rpoS in Escherichia coli O157 manure-amended soil survival and distribution of allelic variations among bovine, food and clinical isolates. FEMS Microbiol. Lett. 338:18-23. http://dx.doi.org/10.1111/1574-6968.12024.
26. Oswald E, Schmidt H, Morabito S, Karch H, Marches O, Caprioli A. 2000. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68:64-71. http://dx.doi.org/10.1128/IAI.68.1.64-71.2000.
27. Morabito S, Karch H, Schmidt H, Minelli F, Mariani-Kurkdjian P, Allerberger F, Bettelheim KA, Caprioli A. 1999. Molecular characterisation of verocytotoxin-producing Escherichia coli of serogroup O111 from different countries. J. Med. Microbiol. 48:891-896. http://dx.doi.org/10.1099/00222615-48-10-891.
28. Schmidt H, Beutin L, Karch H. 1995. Molecular analysis of the plasmidencoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1061.
29. Morabito S, Tozzoli R, Oswald E, Caprioli A. 2003. A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli. Infect. Immun. 71:3343-3348. http://dx.doi.org/10.1128/IAI.71.6.3343-3348.2003.
30. Mellor GE, Besser TE, Davis MA, Beavis B, Jung W, Smith HV, Jennison AV, Doyle CJ, Chandry PS, Gobius KS, Fegan N. 2013. Multilocus genotype analysis of Escherichia coli O157 isolates from Australia and the United States provides evidence of geographic divergence. Appl. Environ. Microbiol. 79:5050-5058. http://dx.doi.org/10.1128/AEM.01525-13.
31. Karlin S, Altschul SF. 1990. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc. Natl. Acad. Sci. U. S. A. 87:2264-2268. http://dx.doi.org/10.1073/pnas.87.6.2264.
32. Perelle S, Dilasser F, Grout J, Fach P. 2004. Detection by 5'-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world's most frequent clinical cases. Mol. Cell. Probes 18:185-192. http://dx.doi.org/10.1016/j.mcp.2003.12.004.
33. Ram S, Shanker R. 2005. Computing TaqMan probes for multiplex PCR detection of E. coli O157 serotypes in water. In Silico Biol. 5:499-504.
34. Roe AJ, Yull H, Naylor SW, Woodward MJ, Smith DG, Gally DL. 2003. Heterogeneous surface expression of EspA translocon filaments by Escherichia coli O157:H7 is controlled at the posttranscriptional level. Infect. Immun. 71:5900-5909. http://dx.doi.org/10.1128/IAI.71.10.5900-5909.2003.
35. Watarai M, Sato T, Kobayashi M, Shimizu T, Yamasaki S, Tobe T, Sasakawa C, Takeda Y. 1998. Identification and characterization of a newly isolated Shiga toxin 2-converting phage from Shiga toxinproducing Escherichia coli. Infect. Immun. 66:4100-4107.
36. Mellor GE, Sim EM, Barlow RS, D'Astek BA, Galli L, Chinen I, Rivas M, Gobius KS. 2012. Phylogenetically related Argentinean and Australian Escherichia coli O157 isolates are distinguished by virulence clades and alternative Shiga toxin 1 and 2 prophages. Appl. Environ. Microbiol. 78: 4724-4731. http://dx.doi.org/10.1128/AEM.00365-12.
37. Wagner PL, Neely MN, Zhang X, Acheson DW, Waldor MK, Friedman DI. 2001. Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J. Bacteriol. 183:2081-2085. http://dx.doi.org/10.1128/JB.183.6.2081-2085.2001.
38. Xu X, McAteer SP, Tree JJ, Shaw DJ, Wolfson EB, Beatson SA, Roe AJ, Allison LJ, Chase-Topping ME, Mahajan A, Tozzoli R, Woolhouse ME, Morabito S, Gally DL. 2012. Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli. PLoS Pathog. 8:e1002672. http://dx.doi.org/10.1371/journal.ppat.1002672.
39. Tree JJ, Roe AJ, Flockhart A, McAteer SP, Xu X, Shaw D, Mahajan A, Beatson SA, Best A, Lotz S, Woodward MJ, La Ragione R, Murphy KC, Leong JM, Gally DL. 2011. Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 80:1349-1365. http://dx.doi.org/10.1111/j.1365-2958.2011.07650.x.
40. Roe AJ, Naylor SW, Spears KJ, Yull HM, Dransfield TA, Oxford M, McKendrick IJ, Porter M, Woodward MJ, Smith DG, Gally DL. 2004. Co-ordinate single-cell expression of LEE4-and LEE5-encoded proteins of Escherichia coli O157:H7. Mol. Microbiol. 54:337-352. http://dx.doi.org/10.1111/j.1365-2958.2004.04277.x.
41. Besser TE, Shaikh N, Holt NJ, Tarr PI, Konkel ME, Malik-Kale P, Walsh CW, Whittam TS, Bono JL. 2007. Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans. Appl. Environ. Microbiol. 73:671-679. http://dx.doi.org/10.1128/AEM.01035-06.
42. Pradel N, Boukhors K, Bertin Y, Forestier C, Martin C, Livrelli V. 2001. Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France. Appl. Environ. Microbiol. 67:2460-2468. http://dx.doi.org/10.1128/AEM.67.6.2460-2468.2001.
43. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
44. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520. http://dx.doi.org/10.1016/S0092-8674(00)80437-7.
45. Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. U. S. A. 87:7839-7843. http://dx.doi.org/10.1073/pnas.87.20.7839.
46. Flockhart AF, Tree JJ, Xu X, Karpiyevich M, McAteer SP, Rosenblum R, Shaw DJ, Low CJ, Best A, Gannon V, Laing C, Murphy KC, Leong JM, Schneiders T, La Ragione R, Gally DL. 2012. Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion. Mol. Microbiol. 83:208-223. http://dx.doi.org/10.1111/j.1365-2958.2011.07927.x.
47. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5:e11147. http://dx.doi.org/10.1371/journal.pone.0011147.